nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—DRD1—nerve—multiple sclerosis	0.0197	0.108	CbGeAlD
Fenoldopam—Myocardial ischaemia—Cladribine—multiple sclerosis	0.0117	0.0257	CcSEcCtD
Fenoldopam—DRD2—nerve—multiple sclerosis	0.0116	0.0641	CbGeAlD
Fenoldopam—ADRA2A—peripheral nervous system—multiple sclerosis	0.0116	0.0637	CbGeAlD
Fenoldopam—Injection site reaction—Cladribine—multiple sclerosis	0.00933	0.0206	CcSEcCtD
Fenoldopam—Bradycardia—Fingolimod—multiple sclerosis	0.00846	0.0187	CcSEcCtD
Fenoldopam—DRD1—brainstem—multiple sclerosis	0.00846	0.0465	CbGeAlD
Fenoldopam—Myocardial ischaemia—Mitoxantrone—multiple sclerosis	0.00767	0.0169	CcSEcCtD
Fenoldopam—Back pain—Fingolimod—multiple sclerosis	0.007	0.0154	CcSEcCtD
Fenoldopam—Cardiac failure—Cladribine—multiple sclerosis	0.00698	0.0154	CcSEcCtD
Fenoldopam—Palpitations—Fingolimod—multiple sclerosis	0.0064	0.0141	CcSEcCtD
Fenoldopam—Blood urea increased—Mitoxantrone—multiple sclerosis	0.00582	0.0128	CcSEcCtD
Fenoldopam—DRD5—nervous system—multiple sclerosis	0.0058	0.0319	CbGeAlD
Fenoldopam—DRD5—central nervous system—multiple sclerosis	0.00558	0.0307	CbGeAlD
Fenoldopam—Hypotension—Fingolimod—multiple sclerosis	0.00552	0.0122	CcSEcCtD
Fenoldopam—DRD1—midbrain—multiple sclerosis	0.00539	0.0297	CbGeAlD
Fenoldopam—Dyspnoea—Fingolimod—multiple sclerosis	0.00527	0.0116	CcSEcCtD
Fenoldopam—Urinary tract infection—Cladribine—multiple sclerosis	0.0051	0.0112	CcSEcCtD
Fenoldopam—ADRA1A—brainstem—multiple sclerosis	0.0051	0.0281	CbGeAlD
Fenoldopam—DRD2—brainstem—multiple sclerosis	0.005	0.0275	CbGeAlD
Fenoldopam—Leukocytosis—Methylprednisolone—multiple sclerosis	0.00494	0.0109	CcSEcCtD
Fenoldopam—DRD2—retina—multiple sclerosis	0.00482	0.0265	CbGeAlD
Fenoldopam—ADRA1B—nervous system—multiple sclerosis	0.00475	0.0262	CbGeAlD
Fenoldopam—Haemoglobin—Cladribine—multiple sclerosis	0.00474	0.0104	CcSEcCtD
Fenoldopam—Haemorrhage—Cladribine—multiple sclerosis	0.00471	0.0104	CcSEcCtD
Fenoldopam—ADRA1D—nervous system—multiple sclerosis	0.00465	0.0256	CbGeAlD
Fenoldopam—Cardiac failure—Mitoxantrone—multiple sclerosis	0.00459	0.0101	CcSEcCtD
Fenoldopam—ADRA1B—central nervous system—multiple sclerosis	0.00458	0.0252	CbGeAlD
Fenoldopam—Leukocytosis—Betamethasone—multiple sclerosis	0.00449	0.00991	CcSEcCtD
Fenoldopam—Leukocytosis—Dexamethasone—multiple sclerosis	0.00449	0.00991	CcSEcCtD
Fenoldopam—ADRA1D—central nervous system—multiple sclerosis	0.00448	0.0246	CbGeAlD
Fenoldopam—DRD5—brain—multiple sclerosis	0.00443	0.0244	CbGeAlD
Fenoldopam—DRD1—nervous system—multiple sclerosis	0.00443	0.0244	CbGeAlD
Fenoldopam—DRD1—central nervous system—multiple sclerosis	0.00427	0.0235	CbGeAlD
Fenoldopam—Blood creatinine increased—Mitoxantrone—multiple sclerosis	0.0042	0.00925	CcSEcCtD
Fenoldopam—Hypokalaemia—Mitoxantrone—multiple sclerosis	0.00408	0.00898	CcSEcCtD
Fenoldopam—Diarrhoea—Fingolimod—multiple sclerosis	0.00404	0.00891	CcSEcCtD
Fenoldopam—Back pain—Cladribine—multiple sclerosis	0.00397	0.00875	CcSEcCtD
Fenoldopam—Leukocytosis—Prednisone—multiple sclerosis	0.00391	0.00863	CcSEcCtD
Fenoldopam—Dizziness—Fingolimod—multiple sclerosis	0.00391	0.00861	CcSEcCtD
Fenoldopam—Haemoglobin—Azathioprine—multiple sclerosis	0.00385	0.00849	CcSEcCtD
Fenoldopam—Haemorrhage—Azathioprine—multiple sclerosis	0.00383	0.00845	CcSEcCtD
Fenoldopam—Headache—Fingolimod—multiple sclerosis	0.0037	0.00816	CcSEcCtD
Fenoldopam—ADRA1B—brain—multiple sclerosis	0.00363	0.02	CbGeAlD
Fenoldopam—ADRA1D—brain—multiple sclerosis	0.00355	0.0196	CbGeAlD
Fenoldopam—Chest pain—Cladribine—multiple sclerosis	0.00349	0.0077	CcSEcCtD
Fenoldopam—Anxiety—Cladribine—multiple sclerosis	0.00348	0.00767	CcSEcCtD
Fenoldopam—Cardiac failure—Methylprednisolone—multiple sclerosis	0.00345	0.00761	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Mitoxantrone—multiple sclerosis	0.0034	0.0075	CcSEcCtD
Fenoldopam—ADRA2C—medulla oblongata—multiple sclerosis	0.00339	0.0186	CbGeAlD
Fenoldopam—DRD1—brain—multiple sclerosis	0.00339	0.0186	CbGeAlD
Fenoldopam—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.00338	0.00746	CcSEcCtD
Fenoldopam—Urinary tract infection—Mitoxantrone—multiple sclerosis	0.00335	0.00739	CcSEcCtD
Fenoldopam—Oliguria—Methotrexate—multiple sclerosis	0.00334	0.00735	CcSEcCtD
Fenoldopam—Sweating—Mitoxantrone—multiple sclerosis	0.00331	0.00729	CcSEcCtD
Fenoldopam—Tachycardia—Cladribine—multiple sclerosis	0.00327	0.0072	CcSEcCtD
Fenoldopam—Hyperhidrosis—Cladribine—multiple sclerosis	0.00324	0.00714	CcSEcCtD
Fenoldopam—DRD2—midbrain—multiple sclerosis	0.00318	0.0175	CbGeAlD
Fenoldopam—Bradycardia—Mitoxantrone—multiple sclerosis	0.00315	0.00695	CcSEcCtD
Fenoldopam—Cardiac failure—Dexamethasone—multiple sclerosis	0.00314	0.00692	CcSEcCtD
Fenoldopam—Cardiac failure—Betamethasone—multiple sclerosis	0.00314	0.00692	CcSEcCtD
Fenoldopam—Hypotension—Cladribine—multiple sclerosis	0.00313	0.0069	CcSEcCtD
Fenoldopam—Haemoglobin—Mitoxantrone—multiple sclerosis	0.00311	0.00686	CcSEcCtD
Fenoldopam—Haemorrhage—Mitoxantrone—multiple sclerosis	0.0031	0.00683	CcSEcCtD
Fenoldopam—ADRA2C—midbrain—multiple sclerosis	0.0031	0.017	CbGeAlD
Fenoldopam—Insomnia—Cladribine—multiple sclerosis	0.00303	0.00668	CcSEcCtD
Fenoldopam—ADRA2C—spinal cord—multiple sclerosis	0.00302	0.0166	CbGeAlD
Fenoldopam—Dyspnoea—Cladribine—multiple sclerosis	0.00299	0.00658	CcSEcCtD
Fenoldopam—Constipation—Cladribine—multiple sclerosis	0.00286	0.00631	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.00279	0.00615	CcSEcCtD
Fenoldopam—Hypokalaemia—Betamethasone—multiple sclerosis	0.00279	0.00615	CcSEcCtD
Fenoldopam—Hypokalaemia—Dexamethasone—multiple sclerosis	0.00279	0.00615	CcSEcCtD
Fenoldopam—Myocardial infarction—Prednisolone—multiple sclerosis	0.00278	0.00612	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00274	0.00604	CcSEcCtD
Fenoldopam—Cardiac failure—Prednisone—multiple sclerosis	0.00274	0.00603	CcSEcCtD
Fenoldopam—ADRA2A—medulla oblongata—multiple sclerosis	0.0027	0.0149	CbGeAlD
Fenoldopam—ADRA1A—nervous system—multiple sclerosis	0.00267	0.0147	CbGeAlD
Fenoldopam—Abdominal pain—Cladribine—multiple sclerosis	0.00265	0.00584	CcSEcCtD
Fenoldopam—Body temperature increased—Cladribine—multiple sclerosis	0.00265	0.00584	CcSEcCtD
Fenoldopam—DRD2—nervous system—multiple sclerosis	0.00262	0.0144	CbGeAlD
Fenoldopam—Back pain—Mitoxantrone—multiple sclerosis	0.00261	0.00575	CcSEcCtD
Fenoldopam—Bradycardia—Prednisolone—multiple sclerosis	0.00259	0.0057	CcSEcCtD
Fenoldopam—ADRA1A—central nervous system—multiple sclerosis	0.00257	0.0142	CbGeAlD
Fenoldopam—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.00257	0.00566	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.00256	0.00565	CcSEcCtD
Fenoldopam—Haemoglobin—Prednisolone—multiple sclerosis	0.00255	0.00563	CcSEcCtD
Fenoldopam—Myocardial infarction—Triamcinolone—multiple sclerosis	0.00255	0.00563	CcSEcCtD
Fenoldopam—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.00255	0.00561	CcSEcCtD
Fenoldopam—ADRA2C—nervous system—multiple sclerosis	0.00255	0.014	CbGeAlD
Fenoldopam—Hypotension—Azathioprine—multiple sclerosis	0.00254	0.00561	CcSEcCtD
Fenoldopam—Haemorrhage—Prednisolone—multiple sclerosis	0.00254	0.0056	CcSEcCtD
Fenoldopam—DRD2—central nervous system—multiple sclerosis	0.00252	0.0139	CbGeAlD
Fenoldopam—ADRA1A—cerebellum—multiple sclerosis	0.00251	0.0138	CbGeAlD
Fenoldopam—Sweating—Methylprednisolone—multiple sclerosis	0.00249	0.00549	CcSEcCtD
Fenoldopam—ADRA2A—midbrain—multiple sclerosis	0.00247	0.0136	CbGeAlD
Fenoldopam—DRD2—cerebellum—multiple sclerosis	0.00246	0.0136	CbGeAlD
Fenoldopam—ADRA2C—central nervous system—multiple sclerosis	0.00245	0.0135	CbGeAlD
Fenoldopam—Hypokalaemia—Prednisone—multiple sclerosis	0.00243	0.00536	CcSEcCtD
Fenoldopam—ADRA2A—spinal cord—multiple sclerosis	0.00241	0.0133	CbGeAlD
Fenoldopam—ADRA2C—cerebellum—multiple sclerosis	0.0024	0.0132	CbGeAlD
Fenoldopam—Bradycardia—Triamcinolone—multiple sclerosis	0.00238	0.00525	CcSEcCtD
Fenoldopam—Bradycardia—Methylprednisolone—multiple sclerosis	0.00237	0.00523	CcSEcCtD
Fenoldopam—Haemoglobin—Triamcinolone—multiple sclerosis	0.00235	0.00518	CcSEcCtD
Fenoldopam—Haemoglobin—Methylprednisolone—multiple sclerosis	0.00234	0.00517	CcSEcCtD
Fenoldopam—Haemorrhage—Triamcinolone—multiple sclerosis	0.00234	0.00515	CcSEcCtD
Fenoldopam—Haemorrhage—Methylprednisolone—multiple sclerosis	0.00233	0.00514	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.00233	0.00513	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.00233	0.00513	CcSEcCtD
Fenoldopam—Myocardial infarction—Dexamethasone—multiple sclerosis	0.00232	0.0051	CcSEcCtD
Fenoldopam—Myocardial infarction—Betamethasone—multiple sclerosis	0.00232	0.0051	CcSEcCtD
Fenoldopam—Chest pain—Mitoxantrone—multiple sclerosis	0.0023	0.00506	CcSEcCtD
Fenoldopam—Diarrhoea—Cladribine—multiple sclerosis	0.00229	0.00505	CcSEcCtD
Fenoldopam—Anxiety—Mitoxantrone—multiple sclerosis	0.00229	0.00504	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00223	0.00491	CcSEcCtD
Fenoldopam—Dizziness—Cladribine—multiple sclerosis	0.00221	0.00488	CcSEcCtD
Fenoldopam—Bradycardia—Dexamethasone—multiple sclerosis	0.00216	0.00476	CcSEcCtD
Fenoldopam—Bradycardia—Betamethasone—multiple sclerosis	0.00216	0.00476	CcSEcCtD
Fenoldopam—Abdominal pain—Azathioprine—multiple sclerosis	0.00215	0.00474	CcSEcCtD
Fenoldopam—Body temperature increased—Azathioprine—multiple sclerosis	0.00215	0.00474	CcSEcCtD
Fenoldopam—Tachycardia—Mitoxantrone—multiple sclerosis	0.00215	0.00474	CcSEcCtD
Fenoldopam—Haemoglobin—Betamethasone—multiple sclerosis	0.00213	0.0047	CcSEcCtD
Fenoldopam—Haemoglobin—Dexamethasone—multiple sclerosis	0.00213	0.0047	CcSEcCtD
Fenoldopam—Vomiting—Cladribine—multiple sclerosis	0.00213	0.00469	CcSEcCtD
Fenoldopam—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00213	0.00469	CcSEcCtD
Fenoldopam—Haemorrhage—Betamethasone—multiple sclerosis	0.00212	0.00467	CcSEcCtD
Fenoldopam—Haemorrhage—Dexamethasone—multiple sclerosis	0.00212	0.00467	CcSEcCtD
Fenoldopam—Headache—Cladribine—multiple sclerosis	0.0021	0.00462	CcSEcCtD
Fenoldopam—Hypotension—Mitoxantrone—multiple sclerosis	0.00206	0.00453	CcSEcCtD
Fenoldopam—ADRA1A—brain—multiple sclerosis	0.00204	0.0112	CbGeAlD
Fenoldopam—ADRA2A—nervous system—multiple sclerosis	0.00203	0.0112	CbGeAlD
Fenoldopam—Acute coronary syndrome—Prednisone—multiple sclerosis	0.00203	0.00447	CcSEcCtD
Fenoldopam—Myocardial infarction—Prednisone—multiple sclerosis	0.00202	0.00445	CcSEcCtD
Fenoldopam—DRD2—brain—multiple sclerosis	0.002	0.011	CbGeAlD
Fenoldopam—Nausea—Cladribine—multiple sclerosis	0.00199	0.00438	CcSEcCtD
Fenoldopam—Back pain—Triamcinolone—multiple sclerosis	0.00197	0.00434	CcSEcCtD
Fenoldopam—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00196	0.00433	CcSEcCtD
Fenoldopam—ADRA2A—central nervous system—multiple sclerosis	0.00196	0.0108	CbGeAlD
Fenoldopam—ADRA2C—brain—multiple sclerosis	0.00195	0.0107	CbGeAlD
Fenoldopam—ADRA2A—cerebellum—multiple sclerosis	0.00191	0.0105	CbGeAlD
Fenoldopam—Constipation—Mitoxantrone—multiple sclerosis	0.00188	0.00415	CcSEcCtD
Fenoldopam—Bradycardia—Prednisone—multiple sclerosis	0.00188	0.00414	CcSEcCtD
Fenoldopam—Diarrhoea—Azathioprine—multiple sclerosis	0.00186	0.00411	CcSEcCtD
Fenoldopam—Haemoglobin—Prednisone—multiple sclerosis	0.00186	0.00409	CcSEcCtD
Fenoldopam—Haemorrhage—Prednisone—multiple sclerosis	0.00185	0.00407	CcSEcCtD
Fenoldopam—Dizziness—Azathioprine—multiple sclerosis	0.0018	0.00397	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.0018	0.00397	CcSEcCtD
Fenoldopam—Tachycardia—Prednisolone—multiple sclerosis	0.00176	0.00388	CcSEcCtD
Fenoldopam—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00175	0.00385	CcSEcCtD
Fenoldopam—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00174	0.00384	CcSEcCtD
Fenoldopam—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00174	0.00384	CcSEcCtD
Fenoldopam—Vomiting—Azathioprine—multiple sclerosis	0.00173	0.00382	CcSEcCtD
Fenoldopam—Anxiety—Methylprednisolone—multiple sclerosis	0.00172	0.0038	CcSEcCtD
Fenoldopam—Flushing—Prednisone—multiple sclerosis	0.00171	0.00378	CcSEcCtD
Fenoldopam—Headache—Azathioprine—multiple sclerosis	0.00171	0.00376	CcSEcCtD
Fenoldopam—Sweating—Methotrexate—multiple sclerosis	0.00165	0.00363	CcSEcCtD
Fenoldopam—Insomnia—Prednisolone—multiple sclerosis	0.00163	0.0036	CcSEcCtD
Fenoldopam—Tachycardia—Triamcinolone—multiple sclerosis	0.00162	0.00357	CcSEcCtD
Fenoldopam—Nausea—Azathioprine—multiple sclerosis	0.00162	0.00356	CcSEcCtD
Fenoldopam—Tachycardia—Methylprednisolone—multiple sclerosis	0.00162	0.00356	CcSEcCtD
Fenoldopam—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00161	0.00354	CcSEcCtD
Fenoldopam—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.0016	0.00353	CcSEcCtD
Fenoldopam—Anxiety—Dexamethasone—multiple sclerosis	0.00157	0.00345	CcSEcCtD
Fenoldopam—Anxiety—Betamethasone—multiple sclerosis	0.00157	0.00345	CcSEcCtD
Fenoldopam—ADRA2A—brain—multiple sclerosis	0.00155	0.00854	CbGeAlD
Fenoldopam—Haemoglobin—Methotrexate—multiple sclerosis	0.00155	0.00342	CcSEcCtD
Fenoldopam—Hypotension—Methylprednisolone—multiple sclerosis	0.00155	0.00341	CcSEcCtD
Fenoldopam—Haemorrhage—Methotrexate—multiple sclerosis	0.00154	0.0034	CcSEcCtD
Fenoldopam—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00151	0.00332	CcSEcCtD
Fenoldopam—Insomnia—Triamcinolone—multiple sclerosis	0.0015	0.00331	CcSEcCtD
Fenoldopam—Insomnia—Methylprednisolone—multiple sclerosis	0.0015	0.0033	CcSEcCtD
Fenoldopam—Dyspnoea—Triamcinolone—multiple sclerosis	0.00148	0.00326	CcSEcCtD
Fenoldopam—Tachycardia—Dexamethasone—multiple sclerosis	0.00147	0.00324	CcSEcCtD
Fenoldopam—Tachycardia—Betamethasone—multiple sclerosis	0.00147	0.00324	CcSEcCtD
Fenoldopam—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00146	0.00321	CcSEcCtD
Fenoldopam—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00146	0.00321	CcSEcCtD
Fenoldopam—Hypotension—Dexamethasone—multiple sclerosis	0.00141	0.0031	CcSEcCtD
Fenoldopam—Hypotension—Betamethasone—multiple sclerosis	0.00141	0.0031	CcSEcCtD
Fenoldopam—Vomiting—Mitoxantrone—multiple sclerosis	0.0014	0.00308	CcSEcCtD
Fenoldopam—Headache—Mitoxantrone—multiple sclerosis	0.00138	0.00304	CcSEcCtD
Fenoldopam—Anxiety—Prednisone—multiple sclerosis	0.00136	0.00301	CcSEcCtD
Fenoldopam—Insomnia—Dexamethasone—multiple sclerosis	0.00136	0.003	CcSEcCtD
Fenoldopam—Insomnia—Betamethasone—multiple sclerosis	0.00136	0.003	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00135	0.00299	CcSEcCtD
Fenoldopam—Body temperature increased—Triamcinolone—multiple sclerosis	0.00131	0.00289	CcSEcCtD
Fenoldopam—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00131	0.00289	CcSEcCtD
Fenoldopam—Nausea—Mitoxantrone—multiple sclerosis	0.00131	0.00288	CcSEcCtD
Fenoldopam—Back pain—Methotrexate—multiple sclerosis	0.0013	0.00287	CcSEcCtD
Fenoldopam—Tachycardia—Prednisone—multiple sclerosis	0.00128	0.00282	CcSEcCtD
Fenoldopam—Hyperhidrosis—Prednisone—multiple sclerosis	0.00127	0.0028	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00123	0.00272	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00123	0.00272	CcSEcCtD
Fenoldopam—Dizziness—Prednisolone—multiple sclerosis	0.00119	0.00263	CcSEcCtD
Fenoldopam—Abdominal pain—Betamethasone—multiple sclerosis	0.00119	0.00263	CcSEcCtD
Fenoldopam—Body temperature increased—Betamethasone—multiple sclerosis	0.00119	0.00263	CcSEcCtD
Fenoldopam—Body temperature increased—Dexamethasone—multiple sclerosis	0.00119	0.00263	CcSEcCtD
Fenoldopam—Abdominal pain—Dexamethasone—multiple sclerosis	0.00119	0.00263	CcSEcCtD
Fenoldopam—Insomnia—Prednisone—multiple sclerosis	0.00119	0.00262	CcSEcCtD
Fenoldopam—Chest pain—Methotrexate—multiple sclerosis	0.00114	0.00252	CcSEcCtD
Fenoldopam—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00113	0.0025	CcSEcCtD
Fenoldopam—Headache—Prednisolone—multiple sclerosis	0.00113	0.00249	CcSEcCtD
Fenoldopam—Constipation—Prednisone—multiple sclerosis	0.00112	0.00247	CcSEcCtD
Fenoldopam—Dizziness—Triamcinolone—multiple sclerosis	0.0011	0.00242	CcSEcCtD
Fenoldopam—Dizziness—Methylprednisolone—multiple sclerosis	0.0011	0.00242	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00107	0.00237	CcSEcCtD
Fenoldopam—Nausea—Prednisolone—multiple sclerosis	0.00107	0.00236	CcSEcCtD
Fenoldopam—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00106	0.00234	CcSEcCtD
Fenoldopam—Vomiting—Triamcinolone—multiple sclerosis	0.00106	0.00233	CcSEcCtD
Fenoldopam—Vomiting—Methylprednisolone—multiple sclerosis	0.00105	0.00232	CcSEcCtD
Fenoldopam—Headache—Triamcinolone—multiple sclerosis	0.00104	0.00229	CcSEcCtD
Fenoldopam—Headache—Methylprednisolone—multiple sclerosis	0.00104	0.00229	CcSEcCtD
Fenoldopam—Abdominal pain—Prednisone—multiple sclerosis	0.00104	0.00229	CcSEcCtD
Fenoldopam—Body temperature increased—Prednisone—multiple sclerosis	0.00104	0.00229	CcSEcCtD
Fenoldopam—Diarrhoea—Dexamethasone—multiple sclerosis	0.00103	0.00227	CcSEcCtD
Fenoldopam—Diarrhoea—Betamethasone—multiple sclerosis	0.00103	0.00227	CcSEcCtD
Fenoldopam—Hypotension—Methotrexate—multiple sclerosis	0.00102	0.00226	CcSEcCtD
Fenoldopam—Dizziness—Betamethasone—multiple sclerosis	0.000996	0.0022	CcSEcCtD
Fenoldopam—Dizziness—Dexamethasone—multiple sclerosis	0.000996	0.0022	CcSEcCtD
Fenoldopam—Insomnia—Methotrexate—multiple sclerosis	0.000992	0.00219	CcSEcCtD
Fenoldopam—Nausea—Triamcinolone—multiple sclerosis	0.000986	0.00217	CcSEcCtD
Fenoldopam—Nausea—Methylprednisolone—multiple sclerosis	0.000984	0.00217	CcSEcCtD
Fenoldopam—Dyspnoea—Methotrexate—multiple sclerosis	0.000978	0.00216	CcSEcCtD
Fenoldopam—Vomiting—Dexamethasone—multiple sclerosis	0.000958	0.00211	CcSEcCtD
Fenoldopam—Vomiting—Betamethasone—multiple sclerosis	0.000958	0.00211	CcSEcCtD
Fenoldopam—Headache—Betamethasone—multiple sclerosis	0.000944	0.00208	CcSEcCtD
Fenoldopam—Headache—Dexamethasone—multiple sclerosis	0.000944	0.00208	CcSEcCtD
Fenoldopam—Diarrhoea—Prednisone—multiple sclerosis	0.000898	0.00198	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000897	0.00198	CcSEcCtD
Fenoldopam—Nausea—Dexamethasone—multiple sclerosis	0.000895	0.00197	CcSEcCtD
Fenoldopam—Nausea—Betamethasone—multiple sclerosis	0.000895	0.00197	CcSEcCtD
Fenoldopam—Dizziness—Prednisone—multiple sclerosis	0.000868	0.00191	CcSEcCtD
Fenoldopam—Abdominal pain—Methotrexate—multiple sclerosis	0.000867	0.00191	CcSEcCtD
Fenoldopam—Body temperature increased—Methotrexate—multiple sclerosis	0.000867	0.00191	CcSEcCtD
Fenoldopam—Vomiting—Prednisone—multiple sclerosis	0.000834	0.00184	CcSEcCtD
Fenoldopam—Headache—Prednisone—multiple sclerosis	0.000822	0.00181	CcSEcCtD
Fenoldopam—Nausea—Prednisone—multiple sclerosis	0.000779	0.00172	CcSEcCtD
Fenoldopam—Diarrhoea—Methotrexate—multiple sclerosis	0.00075	0.00165	CcSEcCtD
Fenoldopam—Dizziness—Methotrexate—multiple sclerosis	0.000725	0.0016	CcSEcCtD
Fenoldopam—Vomiting—Methotrexate—multiple sclerosis	0.000697	0.00154	CcSEcCtD
Fenoldopam—Headache—Methotrexate—multiple sclerosis	0.000687	0.00151	CcSEcCtD
Fenoldopam—Nausea—Methotrexate—multiple sclerosis	0.000651	0.00144	CcSEcCtD
Fenoldopam—DRD5—Signaling Pathways—CD80—multiple sclerosis	0.000108	0.000297	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	0.000108	0.000295	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PGR—multiple sclerosis	0.000107	0.000295	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—BCHE—multiple sclerosis	0.000107	0.000293	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000106	0.000291	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—POMC—multiple sclerosis	0.000106	0.000291	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CXCR3—multiple sclerosis	0.000105	0.000289	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	0.000105	0.000288	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CD28—multiple sclerosis	0.000104	0.000286	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—POMC—multiple sclerosis	0.000104	0.000286	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CNR1—multiple sclerosis	0.000104	0.000286	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—TGFB1—multiple sclerosis	0.000104	0.000284	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	0.000103	0.000284	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—POMC—multiple sclerosis	0.000103	0.000283	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—POMC—multiple sclerosis	0.000103	0.000282	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—TYK2—multiple sclerosis	0.000103	0.000282	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CNR1—multiple sclerosis	0.000103	0.000281	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCR2—multiple sclerosis	0.000102	0.000281	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—MAPK1—multiple sclerosis	0.000102	0.000279	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	0.000101	0.000278	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—TYK2—multiple sclerosis	0.000101	0.000278	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	0.000101	0.000278	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—CCL2—multiple sclerosis	0.000101	0.000277	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—IL2—multiple sclerosis	0.000101	0.000276	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CCL2—multiple sclerosis	0.000101	0.000276	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	0.000101	0.000276	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CXCL10—multiple sclerosis	0.0001	0.000275	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	0.0001	0.000274	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	9.87e-05	0.000271	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	9.86e-05	0.00027	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CD86—multiple sclerosis	9.86e-05	0.00027	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—MAPK1—multiple sclerosis	9.85e-05	0.00027	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	9.76e-05	0.000268	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CD86—multiple sclerosis	9.73e-05	0.000267	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CCL5—multiple sclerosis	9.71e-05	0.000266	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—TGFB1—multiple sclerosis	9.67e-05	0.000265	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—POMC—multiple sclerosis	9.63e-05	0.000264	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—POMC—multiple sclerosis	9.62e-05	0.000264	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	9.61e-05	0.000264	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCL5—multiple sclerosis	9.58e-05	0.000263	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—MAPK1—multiple sclerosis	9.49e-05	0.00026	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—POMC—multiple sclerosis	9.47e-05	0.00026	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CNR1—multiple sclerosis	9.46e-05	0.000259	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	9.43e-05	0.000259	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—CCL2—multiple sclerosis	9.42e-05	0.000258	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—IL2—multiple sclerosis	9.42e-05	0.000258	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CXCL10—multiple sclerosis	9.38e-05	0.000257	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	9.34e-05	0.000256	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—IL2—multiple sclerosis	9.29e-05	0.000255	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—CCL2—multiple sclerosis	9.27e-05	0.000254	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	9.27e-05	0.000254	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CXCL10—multiple sclerosis	9.23e-05	0.000253	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	9.17e-05	0.000252	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—TYK2—multiple sclerosis	9.16e-05	0.000251	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TYK2—multiple sclerosis	9.14e-05	0.000251	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	9.11e-05	0.00025	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—SPP1—multiple sclerosis	8.99e-05	0.000247	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—SPP1—multiple sclerosis	8.87e-05	0.000243	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CD86—multiple sclerosis	8.78e-05	0.000241	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CCR5—multiple sclerosis	8.74e-05	0.00024	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—POMC—multiple sclerosis	8.73e-05	0.00024	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCL5—multiple sclerosis	8.65e-05	0.000237	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCR5—multiple sclerosis	8.63e-05	0.000237	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL2RA—multiple sclerosis	8.62e-05	0.000236	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	8.61e-05	0.000236	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—IL2—multiple sclerosis	8.55e-05	0.000235	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—TYK2—multiple sclerosis	8.55e-05	0.000235	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—CCL2—multiple sclerosis	8.55e-05	0.000234	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CXCL10—multiple sclerosis	8.51e-05	0.000233	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL2RA—multiple sclerosis	8.5e-05	0.000233	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	8.46e-05	0.000232	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—IL2—multiple sclerosis	8.44e-05	0.000231	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—TYK2—multiple sclerosis	8.42e-05	0.000231	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	8.42e-05	0.000231	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—IL2—multiple sclerosis	8.39e-05	0.00023	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	8.23e-05	0.000226	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CD86—multiple sclerosis	8.2e-05	0.000225	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	8.2e-05	0.000225	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCL5—multiple sclerosis	8.08e-05	0.000221	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CD86—multiple sclerosis	8.07e-05	0.000221	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	8.01e-05	0.00022	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—APOE—multiple sclerosis	7.96e-05	0.000218	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	7.95e-05	0.000218	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—APOE—multiple sclerosis	7.92e-05	0.000217	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	7.86e-05	0.000215	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—APOE—multiple sclerosis	7.85e-05	0.000215	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—IL2—multiple sclerosis	7.84e-05	0.000215	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	7.82e-05	0.000214	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	7.79e-05	0.000214	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	7.76e-05	0.000213	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	7.71e-05	0.000212	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	7.7e-05	0.000211	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	7.68e-05	0.000211	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	7.65e-05	0.00021	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	7.62e-05	0.000209	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	7.62e-05	0.000209	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IL2—multiple sclerosis	7.6e-05	0.000209	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—IL6—multiple sclerosis	7.57e-05	0.000208	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SPP1—multiple sclerosis	7.48e-05	0.000205	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	7.48e-05	0.000205	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CD86—multiple sclerosis	7.44e-05	0.000204	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	7.36e-05	0.000202	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCL5—multiple sclerosis	7.33e-05	0.000201	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCR5—multiple sclerosis	7.28e-05	0.0002	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MMP9—multiple sclerosis	7.2e-05	0.000197	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CD80—multiple sclerosis	7.19e-05	0.000197	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	7.17e-05	0.000197	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL2RA—multiple sclerosis	7.17e-05	0.000197	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	7.16e-05	0.000196	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—IL2—multiple sclerosis	7.12e-05	0.000195	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	7.11e-05	0.000195	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CD80—multiple sclerosis	7.1e-05	0.000195	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	7.09e-05	0.000194	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	7.06e-05	0.000194	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	7.06e-05	0.000194	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	7e-05	0.000192	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	6.95e-05	0.000191	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	6.85e-05	0.000188	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—POMC—multiple sclerosis	6.83e-05	0.000187	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—POMC—multiple sclerosis	6.8e-05	0.000187	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SPP1—multiple sclerosis	6.79e-05	0.000186	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—POMC—multiple sclerosis	6.74e-05	0.000185	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CCL2—multiple sclerosis	6.69e-05	0.000183	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	6.66e-05	0.000183	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	6.62e-05	0.000182	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCR5—multiple sclerosis	6.6e-05	0.000181	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCL2—multiple sclerosis	6.6e-05	0.000181	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	6.56e-05	0.00018	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—MAPK1—multiple sclerosis	6.54e-05	0.000179	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	6.54e-05	0.000179	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	6.51e-05	0.000179	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	6.51e-05	0.000178	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—IL2—multiple sclerosis	6.46e-05	0.000177	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—MAPK1—multiple sclerosis	6.46e-05	0.000177	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—APOE—multiple sclerosis	6.43e-05	0.000176	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	6.41e-05	0.000176	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—STAT3—multiple sclerosis	6.4e-05	0.000175	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	6.37e-05	0.000175	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	6.36e-05	0.000174	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	6.27e-05	0.000172	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	6.22e-05	0.000171	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—ALB—multiple sclerosis	6.2e-05	0.00017	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	6.09e-05	0.000167	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	6.08e-05	0.000167	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TYK2—multiple sclerosis	6.07e-05	0.000167	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—APOE—multiple sclerosis	6.01e-05	0.000165	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	5.99e-05	0.000164	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	5.99e-05	0.000164	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	5.96e-05	0.000163	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MYC—multiple sclerosis	5.95e-05	0.000163	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TGFB1—multiple sclerosis	5.93e-05	0.000163	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	5.91e-05	0.000162	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	5.89e-05	0.000162	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	5.83e-05	0.00016	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	5.82e-05	0.00016	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MAPK1—multiple sclerosis	5.82e-05	0.00016	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	5.79e-05	0.000159	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	5.78e-05	0.000159	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	5.69e-05	0.000156	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	5.6e-05	0.000153	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	5.56e-05	0.000153	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—POMC—multiple sclerosis	5.52e-05	0.000151	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	5.48e-05	0.00015	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	5.44e-05	0.000149	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CD80—multiple sclerosis	5.43e-05	0.000149	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	5.41e-05	0.000148	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	5.38e-05	0.000147	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	5.36e-05	0.000147	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	5.23e-05	0.000143	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—POMC—multiple sclerosis	5.16e-05	0.000142	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL2—multiple sclerosis	5.05e-05	0.000139	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	5.05e-05	0.000139	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCL2—multiple sclerosis	5.05e-05	0.000138	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ALB—multiple sclerosis	5.04e-05	0.000138	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—IL6—multiple sclerosis	5.03e-05	0.000138	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	4.99e-05	0.000137	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	4.97e-05	0.000136	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	4.97e-05	0.000136	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	4.96e-05	0.000136	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	4.94e-05	0.000135	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	4.86e-05	0.000133	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	4.86e-05	0.000133	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MMP9—multiple sclerosis	4.78e-05	0.000131	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	4.76e-05	0.000131	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	4.72e-05	0.000129	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	4.62e-05	0.000127	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TYK2—multiple sclerosis	4.58e-05	0.000126	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	4.52e-05	0.000124	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	4.5e-05	0.000123	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	4.48e-05	0.000123	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IL6—multiple sclerosis	4.47e-05	0.000123	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	4.42e-05	0.000121	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	4.42e-05	0.000121	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	4.26e-05	0.000117	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—STAT3—multiple sclerosis	4.25e-05	0.000117	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	4.2e-05	0.000115	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	4.19e-05	0.000115	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	4.18e-05	0.000115	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	4.14e-05	0.000113	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	4.12e-05	0.000113	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	4.1e-05	0.000113	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	3.98e-05	0.000109	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MYC—multiple sclerosis	3.95e-05	0.000108	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TGFB1—multiple sclerosis	3.94e-05	0.000108	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	3.92e-05	0.000107	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	3.9e-05	0.000107	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	3.89e-05	0.000107	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MAPK1—multiple sclerosis	3.86e-05	0.000106	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL2—multiple sclerosis	3.81e-05	0.000105	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	3.81e-05	0.000105	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—IL6—multiple sclerosis	3.8e-05	0.000104	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	3.79e-05	0.000104	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	3.68e-05	0.000101	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	3.66e-05	0.0001	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MMP9—multiple sclerosis	3.61e-05	9.9e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	3.54e-05	9.7e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	3.52e-05	9.65e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	3.51e-05	9.63e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	3.48e-05	9.55e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	3.48e-05	9.54e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	3.44e-05	9.44e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	3.41e-05	9.36e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	3.4e-05	9.32e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	3.29e-05	9.02e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	3.28e-05	8.99e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	3.24e-05	8.87e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	3.23e-05	8.86e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	3.23e-05	8.85e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	3.22e-05	8.82e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—STAT3—multiple sclerosis	3.21e-05	8.8e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	3.17e-05	8.68e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	3.09e-05	8.48e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MYC—multiple sclerosis	2.98e-05	8.18e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	2.98e-05	8.16e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL6—multiple sclerosis	2.97e-05	8.14e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	2.93e-05	8.04e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	2.92e-05	8e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	2.87e-05	7.88e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	2.87e-05	7.88e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	2.87e-05	7.86e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	2.81e-05	7.71e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	2.67e-05	7.32e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	2.66e-05	7.3e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	2.65e-05	7.26e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	2.61e-05	7.16e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	2.47e-05	6.78e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	2.43e-05	6.67e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL6—multiple sclerosis	2.24e-05	6.15e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	2.16e-05	5.92e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	2.01e-05	5.5e-05	CbGpPWpGaD
